Key Insights

Highlights

Success Rate

86% trial completion

Published Results

18 trials with published results (6%)

Research Maturity

101 completed trials (35% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.6%

16 terminated out of 285 trials

Success Rate

86.3%

-0.2% vs benchmark

Late-Stage Pipeline

6%

17 trials in Phase 3/4

Results Transparency

18%

18 of 101 completed with results

Key Signals

18 with results86% success16 terminated

Data Visualizations

Phase Distribution

206Total
Not Applicable (151)
Early P 1 (3)
P 1 (19)
P 2 (16)
P 3 (13)
P 4 (4)

Trial Status

Completed101
Recruiting72
Unknown51
Active Not Recruiting22
Terminated16
Not Yet Recruiting11

Trial Success Rate

86.3%

Benchmark: 86.5%

Based on 101 completed trials

Clinical Trials (285)

Showing 20 of 20 trials
NCT07042243Not ApplicableRecruiting

The Florida ASCENT Study

NCT07173101Phase 2Suspended

Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients

NCT06728709Completed

Lung Ultrasound in Critically Ill Obstetrics and Gynecological Patients

NCT07702721Not Yet RecruitingPrimary

Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies

NCT06580002Phase 2Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

NCT07631572Not ApplicableRecruitingPrimary

Cs-131LDR Brachytherapy for Organ-Preserving Irradiation for Recurrent Cervical and Endometrial Cancer

NCT05053230Not ApplicableRecruiting

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

NCT07296887Not ApplicableRecruitingPrimary

CARE Tool Study Aim 3

NCT07502157Not ApplicableNot Yet RecruitingPrimary

Massage, Oncology, Pain, Anxiety, Feasibility

NCT05185947Phase 2CompletedPrimary

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

NCT05562778Not ApplicableRecruitingPrimary

Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

NCT06936878Not ApplicableRecruiting

BOLSTER: Learning New Skills to Thrive

NCT05971303Active Not RecruitingPrimary

Impact of Cultural and Linguistic Backgrounds on Patient Care and Experience of Women With Gynecologic Malignancies

NCT07120100Not ApplicableRecruiting

Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

NCT06139458Not ApplicableRecruitingPrimary

Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2

NCT07398079Recruiting

Pilot Observational Study of an Integrative Cure Stay Program

NCT05044975Not ApplicableCompleted

Improving Sleep in Gynecologic Cancer Survivors

NCT04007770Phase 2Active Not Recruiting

Acupuncture Pilot Study for Cancer-related Cognitive Function

NCT07111039Not ApplicableWithdrawnPrimary

Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila

NCT07591623Not ApplicableNot Yet RecruitingPrimary

OCRA Distress & Unmet Needs

Scroll to load more

Research Network

Activity Timeline